Tamiflu 75mg

Description

Tamiflu 75mg Capsule

Tamiflu 75mg Capsule is an antiviral medicine used to treat and prevent influenza (flu) as well as, swine flu (H1N1 virus). It helps to relieve the symptoms of the flu virus infection like a stuffy or runny nose, sore throat, cough, body aches, tiredness, headache, fever, and chills.

Dosage

Tamiflu 75mg Capsule (Oseltamivir Phosphate) may be taken with or without food. However, when taken with food, tolerability may be enhanced in some patients.

Standard oral dose for the treatment of influenza:

• Adults and Adolescents: The recommended oral dose of Oseltamivir for treatment of influenza in adults and adolescents 13 years and older is 75 mg twice daily for 5 days. Treatment should begin within 2 days of onset of symptoms of influenza.
• Pediatric patients: The safety and efficacy of Oseltamivir for prophylaxis of influenza in pediatric patients younger than 13 years of age have not been established.

Tamiflu 75mg Capsule Recommended oral dose for the treatment of influenza:

• For prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual: 75 mg once daily for at least 7 days. Therapy should begin within 2 days of exposure.
• For prophylaxis during a community outbreak of influenza: 75 mg once daily. Safety and efficacy have been demonstrated for up to 6 weeks. The duration of protection lasts for as long as dosing is continued.

Administration

May be taken with or without food. May be taken with meals to reduce GI discomfort. Cap may be opened & mixed with sweetened food products eg chocolate syr, sweetened condensed milk, apple sauce or yogurt. Swallow mixture immediately after preparation.

Side Effects of Tamiflu 75mg Capsule

Nausea and vomiting are the most commonly reported side effects. These occurrences are usually mild to moderate in severity and occur within the first two days of treatment. In addition to unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, pyrexia, and peritonsillar abscess, unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, pyrexia, and peritonsillar abscess occur in 1% of patients receiving Oseltamivir for treatment.

Pregnancy & Lactation

Pregnancy Category C: There is inadequate human data to assess the risk of Oseltamivir Phosphate to a pregnant woman or her developing fetus.

Mothers who are breastfeeding: The presence of oseltamivir or oseltamivir carboxylate in human milk is unknown. As a result, only use Oseltamivir Phosphate if the possible benefit to the breastfeeding mother outweighs the danger to the breast-fed infant.

Precautions & Warnings of Tamiflu 75mg Capsule

There is no evidence for efficacy of Oseltamivir Phosphate in any illness caused by agents other than influenza viruses Types A and B. Efficacy of Oseltamivir Phosphate in patients who begin treatment after 40 hours of symptoms has not been established.